Clinical trial
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety…
NCT00273039 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00273039 |
|---|---|
| Title | A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder |
| Official title | A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Social Anxiety Disorder, Anxiety Disorders |
| Intervention type | Drug |
| Interventions | paroxetine |
| Enrollment | 242 |
| Start date | Aug 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Oct 26, 2016 |
| Countries | Argentina, Canada, Chile, Costa Rica, Mexico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: